Connection

Benjamin Cowling to Female

This is a "connection" page, showing publications Benjamin Cowling has written about Female.
Connection Strength

0.338
  1. Decreased Use of Broad-Spectrum Antibiotics During the Coronavirus Disease 2019 Epidemic in South Korea. J Infect Dis. 2021 09 17; 224(6):949-955.
    View in: PubMed
    Score: 0.013
  2. Transmission dynamics and control of two epidemic waves of SARS-CoV-2 in South Korea. BMC Infect Dis. 2021 May 26; 21(1):485.
    View in: PubMed
    Score: 0.013
  3. Clustering and superspreading potential of SARS-CoV-2 infections in Hong Kong. Nat Med. 2020 11; 26(11):1714-1719.
    View in: PubMed
    Score: 0.012
  4. Effect of Nonpharmaceutical Interventions on Transmission of Severe Acute Respiratory Syndrome Coronavirus 2, South Korea, 2020. Emerg Infect Dis. 2020 Oct; 26(10):2406-2410.
    View in: PubMed
    Score: 0.012
  5. The Effect of Influenza Vaccination History on Changes in Hemagglutination Inhibition Titers After Receipt of the 2015-2016 Influenza Vaccine in Older Adults in Hong Kong. J Infect Dis. 2020 01 01; 221(1):33-41.
    View in: PubMed
    Score: 0.011
  6. Effectiveness of Partial and Full Influenza Vaccination Among Children Aged <9 Years in Hong Kong, 2011-2019. J Infect Dis. 2019 10 08; 220(10):1568-1576.
    View in: PubMed
    Score: 0.011
  7. Remaining challenges for prevention and control of hand, foot, and mouth disease. Lancet Child Adolesc Health. 2019 06; 3(6):373-374.
    View in: PubMed
    Score: 0.011
  8. Early season estimate of influenza vaccination effectiveness against influenza hospitalisation in children, Hong Kong, winter influenza season 2018/19. Euro Surveill. 2019 Jan; 24(5).
    View in: PubMed
    Score: 0.011
  9. Effectiveness of influenza vaccination on influenza-associated hospitalisations over time among children in Hong Kong: a test-negative case-control study. Lancet Respir Med. 2018 12; 6(12):925-934.
    View in: PubMed
    Score: 0.011
  10. Influenza-like illness and viral aetiology in Hong Kong children. Hong Kong Med J. 2018 Oct; 24 Suppl 6(5):12-15.
    View in: PubMed
    Score: 0.010
  11. Variation in Influenza B Virus Epidemiology by Lineage, China. Emerg Infect Dis. 2018 08; 24(8):1536-1540.
    View in: PubMed
    Score: 0.010
  12. Immune Responses to Twice-Annual Influenza Vaccination in Older Adults in Hong Kong. Clin Infect Dis. 2018 03 05; 66(6):904-912.
    View in: PubMed
    Score: 0.010
  13. Interim estimate of influenza vaccine effectiveness in hospitalised children, Hong Kong, 2017/18. Euro Surveill. 2018 02; 23(8).
    View in: PubMed
    Score: 0.010
  14. Use of influenza antivirals in patients hospitalized in Hong Kong, 2000-2015. PLoS One. 2018; 13(1):e0190306.
    View in: PubMed
    Score: 0.010
  15. Influenza-associated mortality in Yancheng, China, 2011-15. Influenza Other Respir Viruses. 2018 01; 12(1):98-103.
    View in: PubMed
    Score: 0.010
  16. Cohort profile: the China Ageing REespiratory infections Study (CARES), a prospective cohort study in older adults in Eastern China. BMJ Open. 2017 Nov 01; 7(10):e017503.
    View in: PubMed
    Score: 0.010
  17. Preliminary Epidemiologic Assessment of Human Infections With Highly Pathogenic Avian Influenza A(H5N6) Virus, China. Clin Infect Dis. 2017 Aug 01; 65(3):383-388.
    View in: PubMed
    Score: 0.010
  18. Population-Based Pediatric Hospitalization Burden of Lineage-Specific Influenza B in Hong Kong, 2004-2014. Clin Infect Dis. 2017 Jul 15; 65(2):300-307.
    View in: PubMed
    Score: 0.010
  19. Assessment of Virus Interference in a Test-negative Study of Influenza Vaccine Effectiveness. Epidemiology. 2017 07; 28(4):514-524.
    View in: PubMed
    Score: 0.010
  20. Viral Shedding and Transmission Potential of Asymptomatic and Paucisymptomatic Influenza Virus Infections in the Community. Clin Infect Dis. 2017 03 15; 64(6):736-742.
    View in: PubMed
    Score: 0.009
  21. Comparison of incubation period distribution of human infections with MERS-CoV in South Korea and Saudi Arabia. Sci Rep. 2016 10 24; 6:35839.
    View in: PubMed
    Score: 0.009
  22. Association between Severity of MERS-CoV Infection and Incubation Period. Emerg Infect Dis. 2016 Mar; 22(3):526-8.
    View in: PubMed
    Score: 0.009
  23. Brief Report: Incubation Period Duration and Severity of Clinical Disease Following Severe Acute Respiratory Syndrome Coronavirus Infection. Epidemiology. 2015 Sep; 26(5):666-9.
    View in: PubMed
    Score: 0.008
  24. Preliminary epidemiological assessment of MERS-CoV outbreak in South Korea, May to June 2015. Euro Surveill. 2015 Jun 25; 20(25):7-13.
    View in: PubMed
    Score: 0.008
  25. Neutralizing antibody titres in SARS-CoV-2 infections. Nat Commun. 2021 01 04; 12(1):63.
    View in: PubMed
    Score: 0.003
  26. Anxiety levels, precautionary behaviours and public perceptions during the early phase of the COVID-19 outbreak in China: a population-based cross-sectional survey. BMJ Open. 2020 10 08; 10(10):e040910.
    View in: PubMed
    Score: 0.003
  27. SARS-CoV-2 environmental contamination associated with persistently infected COVID-19 patients. Influenza Other Respir Viruses. 2020 11; 14(6):688-699.
    View in: PubMed
    Score: 0.003
  28. Evolving epidemiology and transmission dynamics of coronavirus disease 2019 outside Hubei province, China: a descriptive and modelling study. Lancet Infect Dis. 2020 07; 20(7):793-802.
    View in: PubMed
    Score: 0.003
  29. Estimating clinical severity of COVID-19 from the transmission dynamics in Wuhan, China. Nat Med. 2020 04; 26(4):506-510.
    View in: PubMed
    Score: 0.003
  30. Detection of Covid-19 in Children in Early January 2020 in Wuhan, China. N Engl J Med. 2020 04 02; 382(14):1370-1371.
    View in: PubMed
    Score: 0.003
  31. Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia. N Engl J Med. 2020 03 26; 382(13):1199-1207.
    View in: PubMed
    Score: 0.003
  32. Influenza-associated excess respiratory mortality in China, 2010-15: a population-based study. Lancet Public Health. 2019 09; 4(9):e473-e481.
    View in: PubMed
    Score: 0.003
  33. Feasibility of case-control and test-negative designs to evaluate dengue vaccine effectiveness in Malaysia. Vaccine. 2019 09 16; 37(39):5891-5898.
    View in: PubMed
    Score: 0.003
  34. Self-collected compared with professional-collected swabbing in the diagnosis of influenza in symptomatic individuals: A meta-analysis and assessment of validity. J Clin Virol. 2019 09; 118:28-35.
    View in: PubMed
    Score: 0.003
  35. Effectiveness of EV-A71 vaccination in prevention of paediatric hand, foot, and mouth disease associated with EV-A71 virus infection requiring hospitalisation in Henan, China, 2017-18: a test-negative case-control study. Lancet Child Adolesc Health. 2019 10; 3(10):697-704.
    View in: PubMed
    Score: 0.003
  36. Influenza epidemiology and influenza vaccine effectiveness during the 2015-2016 season: results from the Global Influenza Hospital Surveillance Network. BMC Infect Dis. 2019 May 14; 19(1):415.
    View in: PubMed
    Score: 0.003
  37. Age-specific differences in the dynamics of protective immunity to influenza. Nat Commun. 2019 04 10; 10(1):1660.
    View in: PubMed
    Score: 0.003
  38. Population-based estimates of the burden of pneumonia hospitalizations in Hong Kong, 2011-2015. Eur J Clin Microbiol Infect Dis. 2019 Mar; 38(3):553-561.
    View in: PubMed
    Score: 0.003
  39. Spectrum of Enterovirus Serotypes Causing Uncomplicated Hand, Foot, and Mouth Disease and Enteroviral Diagnostic Yield of Different Clinical Samples. Clin Infect Dis. 2018 11 13; 67(11):1729-1735.
    View in: PubMed
    Score: 0.003
  40. Surveillance and public health response for travelers returning from MERS-CoV affected countries to Gyeonggi Province, Korea, 2016-2017. Travel Med Infect Dis. 2019 Sep - Oct; 31:101350.
    View in: PubMed
    Score: 0.003
  41. Influenza Transmission Dynamics in Urban Households, Managua, Nicaragua, 2012-2014. Emerg Infect Dis. 2018 10; 24(10):1882-1888.
    View in: PubMed
    Score: 0.003
  42. Estimation of excess mortality and hospitalisation associated with the 2009 pandemic influenza. Hong Kong Med J. 2018 Oct; 24 Suppl 6(5):19-22.
    View in: PubMed
    Score: 0.003
  43. The effectiveness of influenza vaccination against medically-attended illnesses in Hong Kong across three years with different degrees of vaccine match, 2014-17. Vaccine. 2018 10 01; 36(41):6117-6123.
    View in: PubMed
    Score: 0.003
  44. Population Serologic Immunity to Human and Avian H2N2 Viruses in the United States and Hong Kong for Pandemic Risk Assessment. J Infect Dis. 2018 08 24; 218(7):1054-1060.
    View in: PubMed
    Score: 0.003
  45. Influenza Vaccine Effectiveness Against Influenza A(H3N2) Hospitalizations in Children in Hong Kong in a Prolonged Season, 2016/2017. J Infect Dis. 2018 04 11; 217(9):1365-1371.
    View in: PubMed
    Score: 0.003
  46. Knowledge, attitudes and practices related to the influenza virus and vaccine among older adults in Eastern China. Vaccine. 2018 05 03; 36(19):2673-2682.
    View in: PubMed
    Score: 0.003
  47. Epidemiology of Recurrent Hand, Foot and Mouth Disease, China, 2008-2015. Emerg Infect Dis. 2018 03; 24(3).
    View in: PubMed
    Score: 0.003
  48. Estimating Influenza Vaccine Effectiveness With the Test-Negative Design Using Alternative Control Groups: A Systematic Review and Meta-Analysis. Am J Epidemiol. 2018 02 01; 187(2):389-397.
    View in: PubMed
    Score: 0.002
  49. Parental perspectives on hand, foot, and mouth disease among children in Hong Kong: a longitudinal study. Epidemiol Infect. 2018 02; 146(3):324-332.
    View in: PubMed
    Score: 0.002
  50. Estimates of global seasonal influenza-associated respiratory mortality: a modelling study. Lancet. 2018 03 31; 391(10127):1285-1300.
    View in: PubMed
    Score: 0.002
  51. Epidemiology of hand, foot and mouth disease in China, 2008 to 2015 prior to the introduction of EV-A71 vaccine. Euro Surveill. 2017 12; 22(50).
    View in: PubMed
    Score: 0.002
  52. Estimating the incubation period of hand, foot and mouth disease for children in different age groups. Sci Rep. 2017 11 28; 7(1):16464.
    View in: PubMed
    Score: 0.002
  53. Epidemiology of Reemerging Scarlet Fever, Hong Kong, 2005-2015. Emerg Infect Dis. 2017 10; 23(10):1707-1710.
    View in: PubMed
    Score: 0.002
  54. Epidemiology of avian influenza A H7N9 virus in human beings across five epidemics in mainland China, 2013-17: an epidemiological study of laboratory-confirmed case series. Lancet Infect Dis. 2017 08; 17(8):822-832.
    View in: PubMed
    Score: 0.002
  55. Influenza vaccine effectiveness against influenza-associated hospitalization in 2015/16 season, Beijing, China. Vaccine. 2017 05 25; 35(23):3129-3134.
    View in: PubMed
    Score: 0.002
  56. Disease burden of 2013-2014 seasonal influenza in adults in Korea. PLoS One. 2017; 12(3):e0172012.
    View in: PubMed
    Score: 0.002
  57. A Comparative Study of Clinical Presentation and Risk Factors for Adverse Outcome in Patients Hospitalised with Acute Respiratory Disease Due to MERS Coronavirus or Other Causes. PLoS One. 2016; 11(11):e0165978.
    View in: PubMed
    Score: 0.002
  58. Generalised cost-effectiveness analysis for breast cancer prevention and care in Hong Kong Chinese. Hong Kong Med J. 2015 Dec; 21 Suppl 6:9-12.
    View in: PubMed
    Score: 0.002
  59. Do low preoperative vitamin D levels reduce the accuracy of quick parathyroid hormone in predicting postthyroidectomy hypocalcemia? Ann Surg Oncol. 2013 Mar; 20(3):739-45.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.